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ZambiaIntroduction: Biofortiﬁcation is the breeding of new varieties of staple foods for increased micronutrient
content. It is seen primarily as a complementary, rural-targeted strategy for better reaching remote pop-
ulations. This paper presents an ex ante analysis of HarvestPlus’ provitamin A maize (PVAM) in Zambia
and highlights an empirical approach based on the Zambian 2005/06 Living Conditions Monitoring
Survey (LCMS). Because more than 115 countries regularly conduct a Household Consumption and
Expenditure Survey (HCES), the approach developed in this LCMS-based study can be applied in many
other countries to analyze varietal adoption and conduct ex ante studies.
Methods: Data from the LCMS and health statistics were used to characterize baseline indicators of vita-
min A intake and Disability Adjusted Life Years (DALYs) lost. The introduction and scaling up of PVAM
was modeled based on program plans, expert opinion and data on key adoption parameters. An adoption
function was speciﬁed and expressed in terms of the percent of farmers expected to adopt PVAM over the
next 30 years. A logistic regression adoption function was estimated and used to identify the speciﬁc
LCMS households adopting, producing and consuming PVAM each year. Information from the IFPRI
International Model for Policy Analysis of Agricultural Commodities and Trade (IMPACT) of yearly maize
production and demand were used to produce annual estimates of PVAM planted, harvested and con-
sumed. Taking into account an LCMS-empirically-informed, speciﬁed market structure, individuals’ addi-
tional vitamin A intake was calculated. The number of DALYs saved were estimated using the change in
vitamin A intake. Combining these estimates with cost data, the cost-effectiveness of PVAM was calcu-
lated.
Results: Assuming an adoption ceiling of 20% over 30 years, implementation of PVAM will result in aver-
age additional intake of 12% of the Estimated Average Requirement (EAR), a 3 percentage point reduction
in the prevalence of inadequate intake, and savings of 23% of total DALYs. Impacts are concentrated
among farming households that have adopted PVAM and consume it from their own production. Their
consumption will result in an average additional vitamin A intake of 172 lg/day, more than 3 times
the additional 54 lg/day among the entire population. Among this group, the reduction in the prevalence
of inadequate intake will be more than 5 times the national average (17.5 percentage points). Valuing a
DALY at $1000, PVAM’s cumulative value of DALYs saved comes to exceed its cumulative total costs start-
ing in 2019. Over 30 years the cost-effectiveness of PVAM in Zambia was estimated to be $24 per DALY
saved, making it very cost-effective.
Conclusion: The methodologies employed in this study provide insights and inputs that can be used to
target farmers who are most likely to adopt, to measure their vitamin A intake and to craft messages
to promote adoption. PVAM is a long term investment that shows great promise in becoming a highly
cost-effective addition to the public health arsenal for combatting micronutrient deﬁciencies if the 20%
adoption rate can be achieved and maintained. Doing so will require effective marketing strategies,
including efforts to couple this nutrition-sensitive intervention with nutrition-speciﬁc activities, such
as targeted nutrition messaging and education, in order to increase the likelihood that adopting farmers
will prioritize production for home consumption.
 2015 The Authors. Published by Elsevier Ltd. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).
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Between 1990 and 2010, the global burden of micronutrient
deﬁciencies fell by more than half (Wang et al., 2012). Among vita-
min A, iron and zinc deﬁciencies, the largest disease burden reduc-
tions were in the burden of vitamin A, yet it still accounts for the
greatest disease burden among these three deﬁciencies. Despite
these positive trends, micronutrient deﬁciencies remain major
public health problems and still rank among the top causes of
death and disability, particularly in Sub-Saharan Africa (Lim
et al., 2012). Globally, the micronutrient disease burden is shoul-
dered disproportionately by a highly vulnerable group in the most
vulnerable countries—children under 5 years of age in sub-Saharan
Africa.
Data on Zambian nutrition status, and particularly on vitamin A,
is dated. That which is available shows the prevalence of vitamin A
deﬁciency (VAD) has remained persistently and unacceptably high.
According to the most recent nationally representative survey, 53%
of children 6–59 months old are VAD (MOST, 2003)—a level well
above the 20% threshold WHO uses to deﬁne when deﬁciencies
constitute a public health problem—and among non-pregnant
women of childbearing age (15–49 years) VAD was found to be
13.4%. These most recent available data are 12 years old, suggest-
ing that there is considerable uncertainty about the current
situation.
Over the past 15 years, Zambia has made and maintained major
commitments to a number of nutrition programs. It has been a pio-
neer in what have come to be the key programmatic foundations of
nutrition policy in the developing world. In 1998, it became the
ﬁrst country in Africa to fortify sugar with vitamin A (Fiedler
et al., 2013a), and in 1999 it became the ﬁrst country in Africa to
implement what has come to be known as Child Health
Week/Child Health Days (UNICEF, 2011). Child Health Weeks
(CHW) are large-scale, mass mobilization-based events undertaken
semi-annually to provide an integrated package of high impact
child health and nutrition interventions, including vitamin A sup-
plementation, de-worming and vaccinations, growth monitoring
and promotion and, intermittently, the distribution of or
re-impregnation of insecticide-treated mosquito nets (Fiedler
et al., 2012b). From its inception, CHW has been a priority program
of the MOH and has achieved high rates of coverage. Still, Zambia’s
pace of progress in improving nutrition status has been slow, par-
ticularly among young children among whom the prevalence rates
of VAD is thought to remain high (NFNC, 2010).1 We estimate that
VAD is annually responsible for roughly 3700 lost lives and nearly
110,000 disability adjusted life-years (DALYs) in Zambia.
In addition to Zambia’s established portfolio of VAD control pro-
grams—which, since 1998, has consisted of CHW and sugar fortiﬁ-
cation—the country has other options for combating VAD. While
not mandated, wheat ﬂour and maize meal fortiﬁcation programs
are under active consideration by the Zambian government which
has drafted regulations for their fortiﬁcation levels (Fiedler et al.,
2013a). Vitamin A-fortiﬁcation of vegetable oil is another possibil-
ity, but one that the country has yet to consider. The most recent
addition to Zambia’s VAD control portfolio is biofortiﬁcation –
the production and consumption of varieties of maize that contain
increased levels of provitamin A.1 The only additional data on vitamin A since the 2003 national survey is from a 24
HR survey conducted in two districts in 2009. That survey estimated the prevalence of
VAD (based on serum retinol concentration levels) at 57% among 24–59 month olds,
roughly the same percentages as the 2003 national survey level estimates reported in
Table 2 and 3. After adjusting serum retinol levels for infection, the 24HR survey
found the VAD level was 48%, and using another methodology (MRDR) to adjust for
infection, it found the prevalence rate was markedly less, 22%, but still above the 20%
threshold above which WHO deﬁnes VAD as constituting a public health problem
(NFNC, 2010).Biofortiﬁcation is the breeding of new varieties of staple foods
for increased macro- and micronutrient content (Bouis et al.,
2011). It is seen primarily as a complementary, rural-targeted
micronutrient program strategy for better reaching remote popula-
tions, which often comprise the majority of the malnourished.
Biofortiﬁcation is the latest micronutrient intervention strategy,
with the ﬁrst releases of biofortiﬁed varieties having begun in just
the last ﬁve years (Gilligan, 2012).
HarvestPlus – a global consortium co-led by the International
Food Policy Research Institute and the International Center for
Tropical Agriculture – has promoted and released seven, conven-
tionally bred, biofortiﬁed crops in 13 countries, and has established
an accelerating rate of progress in both the number of countries
and the varieties with which it is working (Saltzman et al., 2012).
Until 2012, HarvestPlus worked in only Sub-Saharan Africa and
South Asia. Starting that year, it teamed with AGROSALUD, a pro-
gram working to improve the nutrition content of food staples in
Latin American and the Caribbean (AgroSalud, 2011). While there
are a number of other organizations working on the development
of biofortiﬁed staples, to date only HarvestPlus has begun actually
distributing new varieties. Other efforts include four projects that
use genetic engineering and have targeted bananas, cassava, rice
and sorghum: Golden Rice Project (2011), Bio-cassava Plus (Sayre
et al., 2011), African Biofortiﬁed Sorghum (ABS, 2010) and Better
Bananas for Africa (QUT, 2011). In addition, there are three smaller,
more specialized projects (INSTAPA, 2011; BAGELS, 2008;
HarvestZinc, 2011).2
This paper presents an ex ante analysis of one of the HarvestPlus
projects, Zambia’s provitamin A maize (PVAM). Since the 1960s,
over 60% of the total agricultural area planted in major crops
(i.e., sugarcane, rice, wheat, cassava, maize, potatoes, sorghum,
and soybeans) in Zambia has been planted in maize (JAICAF,
2008). Maize dominates the Zambian diet, accounting for more
than half of available dietary energy (FAO, 2012). The biofortiﬁca-
tion of maize in Zambia provides an ideal case study for better
understanding the potential of biofortiﬁcation and the key factors
that condition its impact. The objectives of this ex ante impact
study are to analyze the costs and health beneﬁts of PVAM in order
to assess its promise as an investment and to estimate its
cost-effectiveness to enable readily comparing it to alternative
health investments.
This study highlights a data-driven, highly contextualized
approach based on the Zambian 2005/06 Living Conditions
Monitoring Survey (LCMS) (CSO, 2011). The LCMS is a large scale,
recurrent, multi-purpose, nationally representative household sur-
vey, very similar to a number of other such surveys that are com-
monly conducted throughout the world (e.g., household budget
surveys, integrated household surveys, household income and
expenditure surveys and living conditions monitoring surveys),
which together have been referred to as ‘‘household consumption
and expenditure surveys’’ or HCES (Fiedler et al., 2012a). More than
115 countries regularly conduct an HCES (Dupreiz et al., 2014). The
approach developed in this LCMS-based study, therefore—which
features empirically developing many of the program and market
parameters—can be applied in many other countries to analyze
varietal adoption and conduct ex ante studies. To facilitate others
replicating the approach, we provide considerable detail about sev-
eral of the empirical-methodological innovations. It is noteworthy
that PVAM is now being introduced in four other countries
(Saltzman et al., 2012), each of which has a recent HCES-type of
survey available that could be used to conduct a similar study.2 For a discussion of the political controversies involved in the conventionally bred
versus genetically engineered approaches see Pray et al. (2007) and Stein (2014).
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The key database in this study is the Zambian 2005/06 Living
Conditions Monitoring Survey (LCMS) data. The LCMS was con-
ducted by the Zambian Central Statistical Ofﬁce. The survey
employed a two-stage, stratiﬁed cluster sample designed to pro-
vide reliable estimates at the provincial and national levels. The
sample includes 18,662 households with 97,750 persons. We used
weighted interview data from the 9287 farming households that
were surveyed in the 2005/06 LCMS to develop estimates for the
universe of Zambian maize farmers (CSO, 2011).Overview
Fig. 1 shows the key methodological components of the study
and its data sources for measuring the project’s enhanced vitamin
A-derived health impact. Health statistics together with a proxy for
food consumption data developed from the LCMS were used to
characterize the ‘‘current situation’’ (or baseline) by estimating
the usual intake of vitamin A, the prevalence of inadequate vitamin
A intake and the burden of vitamin A deﬁciency (VAD) measured
using Disability Adjusted Life Years (DALYs).
Next, implementation of the biofortiﬁcation program was mod-
eled using a combination of program plans, expert opinion and
generated data on key adoption parameters. Usual intake of vita-
min A at endline was estimated as baseline vitamin A intake plus
the estimated quantity of PVAM consumed multiplied by the addi-
tional vitamin A from biofortiﬁcation. Using intake estimates at
endline and baseline, new incidence rates of VAD-related health
outcomes were calculated, as were the number of DALYs lost after
the introduction of PVAM, and the total number of DALYs saved
annually. Total health beneﬁts of PVAM were calculated over the
lifespan of PVAM as the sum of the annual DALYs saved over the
lifespan of PVAM.4 The model correctly classiﬁed 85% of Zambia’s hybrid maize farmers from amongEstimates of Vitamin A Intake and DALYs saved
As already noted, the food consumption module from the LCMS
was used to estimate the prevalence of inadequate vitamin A
intake at baseline as described elsewhere (Fiedler et al., 2013b).
The speciﬁc way in which DALYs are deﬁned and operationalized
in this study follows directly from earlier HarvestPlus work
(Stein et al., 2005b). Drawing on the work of Hallberg et al.
(2000) and Zimmerman and Qaim (2004), this methodology cap-
tures dose–response effects of the improved functional health sta-
tus of the portion of the population whose vitamin A intake
inadequacy gap has been reduced by consuming PVAM, and does
so even if that additional intake does not result in a change in
the prevalence of inadequate intake.3
Vitamin A intake data (baseline and endline) are used in con-
junction with age and sex-speciﬁc requirements to develop esti-
mates of the effectiveness of the intervention. The effectiveness
is then averaged over target groups for which clinically-related
health outcomes associated with vitamin A deﬁciency have been
identiﬁed and quantiﬁed, and the averages are used to calculate
new incidence rates for those health outcomes. The new incidence
rates are then used to estimate the number of DALYs lost after the
introduction of biofortiﬁed PVAM.3 It is important to point out that in this study, while the analysis of intake levels is
in terms of the entire population, the discussion of the adequacy of intake does not
include children less than 1 year old. They are excluded from the adequacy analysis
because there are no established vitamin A EARs for this target group.Supply side estimates
Adoption
PVAM has only been available in Zambia in a limited quantity
since November 2012: there are no data regarding PVAM adoption.
PVAM is a hybrid variety of maize. We used LCMS data identifying
hybrid maize growing farmers as a proxy to identify those farmers
who would plant PVAM, and using logistic regression estimated
the likelihood of farmers planting PVAM. Informed by recent
Zambian work of Smale and Mason (2012) on the demand for
maize seed and a maize seed varietal study (De Groote et al.,
2011), the speciﬁcation of the model included an index of agricul-
tural inputs, household labor supply, education, an assets index,
identiﬁed seed sources and the district of residence.4 The LCMS ﬁle
of farmers was then rank-ordered by the farmers’ predicted proba-
bilities of adoption, providing a tool for identifying the ordered like-
lihood in which speciﬁc Zambian maize farmers could be expected to
adopt PVAM.
In order to map out the expansion path of adoption of PVAM, an
adoption function was speciﬁed. The adoption function was also
informed by the De Groote et al. (2011) and Smale and Mason
(2012) studies, as well as the three most recent Zambian Living
Conditions Monitoring Surveys (2003/04, 2005/06 and 2010), the
views and experiences of Zambian public and private sector seed
experts, and Zambian maize value chain experts. The function
was expressed in terms of the percent of farmers (nationwide)
expected to adopt PVAM over the next 30 years and was used with
additional parameters (discussed below) to identify spatial and
temporal dimensions, and to translate the percentage of farmers
into annual estimates of the number of farmers likely to adopt
PVAM.
PAN 53 was found to be the most popular variety, grown by
10.7% of the sampled farmers. The historical adoption experience
of PAN 53 was used as the basic model for the PVAM adoption
function, with some modiﬁcations stemming from several addi-
tional considerations: (1) the long term trend in the adoption rate
of hybrids; (2) a bounce in adoption rates that PVAM’s adoption by
the Zambia Farmer Input Support Program is expected to provide
starting in 2015/16 (Smale and Birol, 2013), and (3) the assumption
that PVAM will be able to achieve an adoption rate higher than
PAN 53’s peak rate to date. This assumption was made because
(a) PAN 53 does not appear to have yet reached its zenith, and
(b) while PAN53 consists of a single variety, PVAM refers to a col-
lection of varieties. The estimated function (Fig. 2), posits that the
adoption rate will reach 16% in the 8th year of implementation,
and thereafter, its annual rate of increase will slow considerably,
reaching its maximum of 20% of all farmers in year 30 (i.e., 2042).Implementation
The decision of where to ﬁrst begin the roll-out of PVAM was
based on national and provincial analysis of the production, dispo-
sition and consumption patterns of maize, and of hybrid maize.
Eastern, Central and Southern provinces were selected as the sites
in which PVAM would ﬁrst be introduced because they exhibited
the most favorable conditions for the introduction of PVAM (i.e.,
high percentages of maize farmers and hybrid maize use; larger
maize farms; and lowest average vitamin A intake). Based on pro-
gram implementation plans, it was assumed that the seed wouldall maize farmers, with a sensitivity of 64.4 and a speciﬁcity of 88.2. Sensitivity is a
measure of how well a logistic regression model predicts true positives; i.e., in this
instance, it correctly identiﬁes as hybrid adopters those who in fact did adopt.
Speciﬁcity is a measure of how well the model correctly categorizes false negatives;
i.e., it correctly identiﬁes as non-adopters of hybrid maize, those who, in fact, do not
adopt it.
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Fig. 2. Provitamin A maize adoption parameters, Zambia 2013–2042. Source: Authors’ calculations.
5 IMPACT is a multi-commodity, multi-country, partial equilibrium model that
generates projections of global food supply, demand, trade and prices. IMPACT
develops estimates of 46 crop and livestock commodities and includes 115
countries/regions which are each inter-linked through international trade and 281
food producing units (grouped according to political boundaries and major river
basins). Demand is a function of prices, income and population growth. Crop
production is determined by crop and input prices, the rate of productivity growth
and water availability (Rosegrant et al., 2012).
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provinces initially. To develop the district-speciﬁc level estimates,
the farmers in the LCMS were rank-ordered within each district by
their predicted probability of adopting PVAM. The farmers’
rank-ordered predicted probabilities of PVAM adoption were used
to identify the speciﬁc farmers who would be the ﬁrst adopters in
2013. The speciﬁc farmers selected were those whose rank-ordered
cumulative number was equal number to the adoption
function-estimated number of adopting farmers. The annual num-
ber of PVAM adopters in each district in a province were aggre-
gated to develop the provincial-level estimated number of PVAM
adopters. Similarly, the annual aggregations of the provincial esti-
mates provided the total national number of farmers adopting
PVAM. After the initial implementation of PVAM in the ﬁrst 3 dis-
tricts of Central, Eastern and Southern provinces, it was assumed
that implementation would begin in all other districts and pro-
vinces in year 2.
Production
Drawing on recent past experiences and the views of public
extension and private seed company specialists, it was assumed
that each household would receive one 5 kg pack of PVAM seed
(this is the standard seed package in Zambia), enough seed to plant
0.25 hectares (or what Zambians refer to as 1 lima). Once speciﬁc
adopters were identiﬁed from the rank-ordered LCMS ﬁle, the area
planted in PVAM by each farmer was estimated based on an initial
assumption of 0.5 limas (half of the seed pack) and increased by 0.5
limas per year up to a farm-speciﬁc maximum set equal to eachfarm’s maximum amount of area planted in maize as identiﬁed
in the LCMS. The total area planted in PVAM was the sum of the
land planted in PVAM by all of the identiﬁed, individual PVAM
farmers.
The estimation of annual changes in PVAM production was also
in part a function of annual changes in total maize production, cul-
tivated area and yield. The source of the 2013–2042 annual data
was the IFPRI International Model for Policy Analysis of
Agricultural Commodities and Trade (IMPAACT).5 IMPACT’s esti-
mates of the changing total maize area were used in combination
with the LCMS-provided baseline area to calculate the rate of change
of total maize area planted, allowing each individual farm’s yield and
area to change annually.
In the ﬁrst year of the analysis it was assumed that PVAM yield
was equal to that attained in HarvestPlus ﬁeld trials, 375 kg/lima
(1500 tons/Ha). In each subsequent year, PVAMyieldwas calculated
by multiplying this initial yield by the annual rate of change of (all)
maize yields as estimated by IMPACT. For each PVAM producer,
multiplying the area planted in PVAM by the IMPACT-estimated
yield provided an estimate of each producer’s PVAM production,
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ual PVAM producers’ output. Based on information from the African
Postharvest Losses Information System (APHLIS, 2012), it was
assumed that all PVAM farmers experience post-harvest losses of
15%.
Demand side estimates
Empirical analysis of the production, disposition, marketing and
consumption of maize guided our approach to modeling PVAM.
Analysis of the LCMS revealed that 68% of all maize consumed in
Zambia is maize that the household consuming it has itself pro-
duced. With respect to the residual, the Food Security Research
Project’s 2008 Supplemental Survey of 7825 smallholders revealed
that maize markets in Zambia are very local phenomena (Mason
and Jayne, 2009). Only 20–25% of the maize produced in Zambia
enters the market, and a substantial share of that which does is
sold at local or district markets. Comparing the agriculture/produc-
tion and consumption modules from the LCMS revealed that each
province has relatively equal quantities of maize production and
maize consumption; each province is, or could be, a largely inde-
pendently functioning market.6 Eastern and Central are the only
exceptions.
These empirical ﬁndings about the adoption, production, con-
sumption and marketing of maize shaped our approach to model-
ing PVAM. It was assumed that all PVAM produced is retained by
the PVAM-producing household to meet its maize consumption
needs, and is not sold until that need is surfeited. Those PVAM
farmers who produce more PVAM than the maximum quantity of
maize they annually consume from their own production, sell
the ‘‘excess’’. The PVAM which is sold was assumed to be sold into
a provincial-level market where it is available for purchase by all
other households—including farming households that have not
adopted PVAM and non-farming households.
In provinces in which the provincial demand for PVAM market
is surfeited, it was assumed that the excess PVAM spills over into
other provinces. In light of the fact that 85% of the maize purchased
in Zambia is purchased either in Lusaka or Copperbelt, the
inter-provincial market was deﬁned as consisting of just these
two provinces. The proportion of households’ maize consumption
that was assumed to be purchased in the market was equal to
the ratio of PVAM in the market (i.e., the residual after PVAM farm-
ers have met their household’s maize consumption needs) to the
amount of maize that is consumed from purchases in the market
(including all maize forms, grain and meals).
The average concentration of provitamin A among the three ini-
tial varieties released in 2012 was 7.5 lg/g (HarvestPlus, 2013). By
2018, it is expected that varieties with 15 lg/g of provitamin A will
be released. Thus in this study, we assumed that the concentration
of provitamin A in PVAM was 7.5 lg/g until 2018, thereafter
increasing to 15 lg/g. In addition, based on studies conducted on
the bioconversion rates of provitamin A to vitamin A when
PVAM is eaten, it was assumed that 6.5 lg of provitamin A would
yield 1 lg of vitamin A (as retinol activity equivalents or RAE)
(HarvestPlus, 2013).
Costs
The value of the resources that will be required to promote,
release, monitor and maintain PVAM in Zambia were estimated
using a combination of HarvestPlus expenditures and budgets,
together with information provided by key Zambian partners and6 We say ‘‘could be’’ because these are net quantities and do not take into account
the timing or cumulative quantities of households’ total maize sales and total maize
purchases over the course of the year.stakeholders. It was assumed that costs started being incurred in
2010 and that there will be an active ‘‘project-like’’ phase from
2010 through 2019, with release occurring in 2013 and promotion
and dissemination efforts continuing through 2019. Thereafter, the
signiﬁcant costs are those related to monitoring the quality of the
PVAM and maintaining the integrity of its seed bank. It was
assumed that this Maintenance & Monitoring (M&M) would con-
tinue throughout the remainder of the accounting period after
the initial release of PVAM. Thus the cost analysis covers a period
of 33 years.
Beneﬁt-cost and cost-effectiveness analysis
The cost-effectiveness of biofortiﬁcation was estimated using
the PVAM cost analysis and the PVAM DALYs saved analysis.
Three measures commonly used in ﬁnancial investment
decision-making were calculated: the cost per DALY saved, the
beneﬁt-cost ratio and the internal rate of return. A value of 3 per-
cent (which is generally used for health projects) was used for the
discount rate. The beneﬁt-cost ratio was calculated by assigning a
ﬁxed value of $1000 per DALY (Meenakshi et al., 2007; Nestel et al.,
2006; Stein et al., 2005a). Finally, a breakeven analysis was per-
formed in order to examine how long it will take for beneﬁts gen-
erated by PVAM to outweigh costs.Results
Adoption and production
Fig. 2 shows the annual number of new adopters, as well as the
cumulative percent and number of adopting farmers over the
30-year period. The peak in the annual number of adopters is
assumed to happen relatively early, in 2019, when the adoption
curve is the steepest during the growth phase. Figs. 3 and 4 show
the production of PVAM and the number of households growing
PVAM annually over the 2013–2042 period. Production of VAM is
dominated by Eastern, Southern and Central provinces.
Marketing and consumption
The size and evolution of the quantities of PVAM involved in the
inter-provincial market are shown in Fig. 5. While both intra- and
inter-provincial markets grow throughout the analytic period,
without question the most dynamic market over time is the
intra-provincial one.
Fig. 6 analyzes households’ consumption levels by their status
as (1) PVAM adopting farmers (Adopter), (2) Non-PVAM Adopting
farmers (Non-Adopters) or (3) non-farming households. Initially,
consumption is concentrated among the PVAM adopters but their
rate of increase in consumption slows in 2022, while the level of
non-farmers continues to increase. By 2027, the non-farmers’ con-
sumption level overtakes that of PVAM adopters. While a larger
proportion of the total beneﬁts are garnered by purchasers as a
group, the average level of beneﬁts accruing to adopting farmers
are greater due to the farmers’ relatively greater average consump-
tion levels.
Vitamin A intake
Baseline
Baseline estimates of vitamin A intake in 2013 and their evolu-
tion over time are shown in Fig. 7. The average intake of Zambians
will improve over the next 30 years in the absence of any vitamin A
intervention due simply to increasing general food consumption
patterns and the changing composition of foods consumed. The
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increasing from 229 to 260 lg/day and from 51.1 to 57.9 percent
of the Estimated Average Requirement (EAR). Those improvements
will result in less than a 2% reduction in the prevalence of inade-
quate intake. The number of DALYs that will be lost due to inade-
quate vitamin A intake will increase more than two and a half
times, increasing from 108,557 to more than 267,056. Other things
being equal, this suggests that Zambia will continue to need vita-
min A intervention programs throughout the next 3 decades.
It is important to note that while the baseline number of DALYs
that Zambia will incur over this period increases each year, this
increase is due to population growth. Controlling for population
growth (by calculating the number of DALYs per 1000 population),
the number of vitamin A-attributable DALYs the average Zambianchild under ﬁve or pregnant-lactating woman will incur over the
next 30 years, will decrease slightly over time, even without any
vitamin A interventions.
Endline
The endline vitamin A intake with biofortiﬁcation is shown in
Fig. 7. In addition, Table 1 presents ﬁve endline indicators for three
populations- the entire population; children under 5 years of age;
and women ages 15–49 years. The major impact of PVAM is con-
centrated in the 8-year period between 2018 and 2025. During
those 8 years, half of the change in the endline indicators made
over the entire 30 period is realized, including: 50% of the increase
in the endline vitamin A intake; 62% of the additional vitamin A
intake; 50% of the increase in the percent of the vitamin A EAR;
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K. Lividini, J.L. Fiedler / Food Policy 54 (2015) 65–77 71and half of the small reduction in prevalence. PVAM is able to
interrupt what is otherwise a steady March upward of the total
number of vitamin A-attributable DALYs in Zambia over the next
30 years. The contribution of PVAM to vitamin A nutriture in
Zambia is the provision of a widely experienced surge in vitamin
A intake that takes the national average intake level to a higher
plane.
Table 2 presents impact measures of PVAM. The ﬁrst three rows
present indicators reporting changes between baseline and endline
values of vitamin A intake (lg/day), changes in prevalence (the
reduction in the percent of inadequate vitamin A intake preva-
lence) and the change in the vitamin A intake as a percent of the
EAR between baseline and endline. With an assumed maximum0
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Fig. 7. Vitamin A intake at baseline and with biofortiﬁed provitamin A maize.
Source: Authors’ calculations.adoption ceiling of 20% over the 30 years, the average impacts
nationwide will be barely visible in the ﬁrst ﬁve years, while adop-
tion is still taking root. Over the 30-year period, however, provita-
min A biofortiﬁcation of maize will result in an average additional
vitamin A intake of 54 lg/day; an additional 12% of the vitamin A
EAR; a reduction in the prevalence of inadequate vitamin A intake
of three percentage points; and a savings of 53,133 DALYs (23% of
the total).
The impact measures just discussed are national average
impacts. How do PVAM’s impacts affect different sub-populations?
Fig. 8 juxtaposes the average additional vitamin A intake of the
entire population, unconditioned on consumption of PVAM, and
farming households that have adopted PVAM and consume it from
their own production. Every year, the average impact of PVAM on
this population is far greater than the nationwide average impact.
In 2042, the average additional vitamin A intakewill be 172 lg/day,
more than 3 times the additional 54 lg/day among the entire popu-
lation. Whereas the reduction in the prevalence of inadequate vita-
min A intake is roughly three percentage points among the entire
population in 2042, among adopters consuming fromhomeproduc-
tion, the reduction will be more than 5 times greater, 17.5 percent-
age points due to their much greater average consumption levels
(Fig. 9).Costs
The cost results are shown in Table 3 by activity and year. The
greatest percentage of costs is accounted for by the administrative
functioning of HarvestPlus’ headquarters and its country ofﬁce.
This is followed by the costs of production and then by identiﬁca-
tion & release and promotion activities.
Fig. 10 shows the evolution of annual costs over the entire ana-
lytic period. The bulk of costs are incurred early-on in the project,
reﬂecting both the ‘‘active project’’ phase and, more speciﬁcally,
the ramping up of activities in preparation for the ‘‘big push’’ for
early, large scale adoption. PVAM annual costs peak just prior to
release in 2012. Thereafter, they slowly decrease until the closing
of the country ofﬁce in 2019, marking the end of the ‘‘active pro-
ject’’ phase. In 2020, they fall precipitously to $200,000 per year,
a level at which they persist, as they come to consist of just
M&M costs.Beneﬁt-cost and cost-effectiveness analysis
Based on this analysis, PVAM will generate a total savings of
1,192,384 DALYs, which have a present value of 649,062 and a cost
Table 1
Endline indicators of biofortiﬁed provitamin A maize by 3-year averages. Source: Authors’ calculations.
Indicator Target pop. 2013–15 2016–18 2019–21 2022–24 2025–27 2028–30 2031–33 2034–36 2037–39 2040–42
Endline vitamin A
Intake (lg/day)
Everyone 230 238 254 273 288 297 304 307 310 312
Children 1–4 129 133 141 151 159 164 167 169 170 171
Children <5 121 125 133 142 149 154 157 158 159 160
Women 15–49 237 244 261 280 296 306 313 317 320 323
Additional vitamin A
intake (lg/day)
Everyone 0 2 14 29 41 48 51 53 53 53
Children 1–4 0 1 7 15 21 25 27 27 27 27
Children <5 0 1 6 14 19 22 24 25 25 24
Women 15–49 0 2 14 30 42 49 53 56 56 55
Percent of vitamin A
EAR
Everyone 51% 53% 56% 61% 64% 66% 68% 68% 69% 69%
Children 1–4 58% 60% 64% 69% 72% 74% 76% 76% 77% 77%
Children <5 58% 60% 64% 69% 72% 74% 76% 76% 77% 77%
Women 15–49 48% 49% 52% 56% 59% 62% 63% 64% 64% 65%
Prevalence of vitamin A
intake inadequacy
Everyone 87% 87% 86% 85% 85% 84% 84% 83% 83% 83%
Children 1–4 85% 85% 84% 83% 82% 81% 81% 81% 80% 80%
Children <5 85% 85% 84% 83% 82% 81% 81% 81% 80% 80%
Women 15–49 83% 83% 82% 81% 80% 80% 79% 79% 79% 79%
Change in prevalence Everyone 0.0% 0.0% 0.4% 1.2% 1.8% 2.3% 2.6% 2.8% 2.8% 2.9%
Children 1–4 0.0% 0.0% 0.4% 1.4% 2.2% 2.8% 2.9% 3.2% 3.4% 3.3%
Children <5 0.0% 0.0% 0.4% 1.4% 2.2% 2.8% 2.9% 3.2% 3.4% 3.3%
Women 15–49 0.0% 0.0% 0.4% 1.1% 1.6% 2.0% 2.4% 2.7% 2.8% 2.8%
Endline DALYs Total DALYs 1,12,086 1,21,756 1,25,262 1,27,485 1,32,157 1,40,704 1,52,244 1,65,718 1,81,436 1,99,292
Children U5 1,09,199 1,18,639 1,22,090 1,24,299 1,28,914 1,37,291 1,48,580 1,61,745 1,77,095 1,94,526
P/L Women 2887 3116 3172 3186 3243 3413 3664 3972 4341 4766
Table 2
Impact measures of biofortiﬁed provitamin A maize by 3-year averages with no other interventions. Source: Authors’ calculations.
Indicator Target pop. 2013–15 2016–18 2019–21 2022–24 2025–27 2028–30 2031–33 2034–36 2037–39 2040–42
Additional vitamin A
intake (lg/day)
Everyone 0 2 14 29 41 48 51 53 53 53
Children 1–4 0 1 7 15 21 25 27 27 27 27
Children <5 0 1 6 14 19 22 24 25 25 24
Women 15–49 0 2 14 30 42 49 53 56 56 55
Change in prevalence
(reduction in %)
Everyone 0.0% 0.0% 0.4% 1.2% 1.8% 2.3% 2.6% 2.8% 2.8% 2.9%
Children 1–4 0.0% 0.0% 0.4% 1.4% 2.2% 2.8% 2.9% 3.2% 3.4% 3.3%
Children <5 0.0% 0.0% 0.4% 1.4% 2.2% 2.8% 2.9% 3.2% 3.4% 3.3%
Women 15–49 0.0% 0.0% 0.4% 1.1% 1.6% 2.0% 2.4% 2.7% 2.8% 2.8%
Change in average EAR
(reduction in %)
Everyone 0.0% 0.5% 3.1% 6.5% 9.1% 10.6% 11.4% 11.8% 11.8% 11.7%
Children 1–4 0.0% 0.5% 3.1% 6.9% 9.6% 11.2% 12.0% 12.4% 12.4% 12.1%
Children U5 0.0% 0.5% 3.1% 6.9% 9.6% 11.2% 12.0% 12.4% 12.4% 12.1%
Women 15–49 0.0% 0.5% 2.8% 6.0% 8.5% 9.9% 10.7% 11.2% 11.2% 11.1%
Number of DALYs
saved-efﬁciency measure
Total DALYs 63 1944 10,898 21,936 31,559 38,649 44,304 49,715 54,862 59,807
Children U5 60 1880 10,564 21,268 30,570 37,419 42,873 48,099 53,070 57,843
P/L Women 3 65 333 668 989 1231 1430 1617 1793 1964
% DALYs saved-efﬁciency
measure
Total DALYs 0.1% 1.5% 8.0% 14.6% 19.3% 21.5% 22.5% 23.1% 23.2% 23.1%
Children U5 0.1% 1.5% 7.9% 14.6% 19.1% 21.4% 22.4% 22.9% 23.1% 22.9%
P/L Women 0.1% 2.0% 9.4% 17.3% 23.3% 26.5% 28.1% 28.9% 29.2% 29.2%
72 K. Lividini, J.L. Fiedler / Food Policy 54 (2015) 65–77of $24 per DALY saved. It has a beneﬁt-cost ratio of 42 and a rate of
return of 40%.
The World Bank and WHO have suggested benchmarks for
interpreting costs per DALY. Based on the World Bank approach,
a public health intervention with a cost per DALY of less than
US$260 is ‘‘very cost-effective’’ (World Bank, 1993).7 Using a differ-
ent comparator, WHO’s CHOICE (Choosing Interventions that are
Cost Effective) Working Group has suggested that a health interven-
tion should be considered ‘‘cost-effective’’ if its cost per DALY saved
is less than 3 times per capita income and it should be regarded as
‘‘very cost-effective’’ if its costs per DALY saved is less than per capita
income (WHO, 2003). Given the 2010 Zambia per capita gross
domestic income of US$1,533 current US$ (World Bank, 2015), and7 This is the authors’ adjusted original 1993 World Development Report ﬁgure,
which was expressed in 1990 dollars. It has been adjusted to the dollar’s average
value in 2011 through November (USBLS, 2012).using the WHO criterion, if the cost per DALY saved is less than
US$4,599 PVAM can be considered a cost-effective intervention,
and if it is less than $1,533 it can be considered ‘‘very
cost-effective’’. By the WHO criterion, PVAM qualiﬁes as a ‘‘very
cost-effective’’ intervention.
In Fig. 11 the breakeven point occurs where the cumulative
costs and cumulative beneﬁts (valuing a DALY saved at $1000)
intersect. PVAM’s cumulative value of DALYs saved comes to
exceed its cumulative total cost occurs starting in 2019, and each
year thereafter its net savings increases.
With its cost front-loaded and its beneﬁts accruing slowly over
time, PVAM is a time sensitive intervention. If the accounting per-
iod is cut from 30 to 20 years, it reduces the DALYs that PVAM
saves much more than it affects costs, and its cost per DALY saved
increases from $24 to $44. If the accounting period is further
reduced to 10 years, PVAM’s cost-effectiveness is further reduced
and its cost per DALY jumps to $235.
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Table 3
Estimated undiscounted costs of the release and scale up of high provitamin A maize in Zambia in thousands of US$. Source: Authors’ calculations.
Activity/sub-activity 2010 2011 2012 2013 2014 2010–14 total 2015 2016 2017 2018 2019 2015–19 total Grand total
1. Nutrition target setting 5 72 467 3 0 547 547
2. Identiﬁcation and release 84 294 200 85 85 748 95 95 95 95 95 475 1223
3. Seed production 1 70 160 260 260 751 150 150 150 150 150 750 1501
4. Seed dissemination 21 80 105 155 363 95 40 40 40 40 287 650
5. Training and extension work 45 120 120 150 435 30 30 30 30 30 150 585
6. Advocacy 15 272 200 487 487
7. Promotion 135 140 230 130 635 130 130 130 130 130 650 1285
8. Impact assessment 100 50 95 105 350 165 15 15 15 265 475 825
9. Administration – country Ofﬁce 163 584 979 912 870 3509 1000 1000 1000 1000 1000 5000 8509
Total 268 1592 2396 1810 1755 7824 1665 1460 1460 1460 1710 7787 15,611
8 For iron and zinc, initial biofortiﬁcation targets are estimated to deliver roughly
30% and 40% of the EAR, respectively.
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Biofortiﬁcation is a nascent technology with promise, but about
which we still know relatively little. It is commonly described as a
new, distinct platform that is food-based; enables targeting a
heretofore neglected population—isolated, subsistence farmers; is
complementary, beginning in rural areas and reaching to urbanareas as markets develop (as opposed to other interventions which
begin in urban areas); which, after an initial investment, becomes
sustainable, low cost and cost-effective; and will deliver roughly
50% of the EAR in the case of vitamin A8 (Bouis et al., 2011).
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intakes for most target populations does not exist, initial targets were
set as ‘‘minimum’’ targets based on assumptions about food consump-
tion, bioavailability, and retention after storage and cooking losses,
and as new information became available, these parameters and tar-
gets would be revised. Formaize, the original estimates assumed con-
sumption of roughly 400 g/day among non-pregnant/non-lactating
women and about 200 g/day among children 4–6 years old (Bouis
et al., 2011). Are the ﬁndings of this study consistent with this
portrait?Targeting isolated, hard-to-reach rural populations initially, and
extending to urban areas as markets develop
Initially, cultivators of PVAM in rural areas consume more
PVAM than either non-adopters or non-farmers and they remain
the largest consuming group for the ﬁrst 15 years. In addition, indi-
vidually, PVAM cultivators beneﬁt relatively more from PVAM than
non-cultivators due to their greater conditional consumption of
PVAM. Overall, however, owing to differences in the sizes of the
groups, most of the beneﬁts of PVAM go to purchasers of PVAM
from both rural and urban areas. Rural areas account for the major-
ity of PVAM consumption initially and cumulatively over the
30 years. Over time, however, urban areas account for an increas-
ing proportion of annual PVAM consumption, and in 2037, the
urban areas’ annual consumption surpasses that of rural areas.
This is consistent with the expectation that biofortiﬁcation would
initially be targeted to rural areas and that its coverage and impact
would extend to urban areas as the PVAM market developed.
In light of PVAM’s high nationwide coverage and impacts, how
does it ﬁt with other possiblemicronutrient interventions? In a sep-
arate analysis of the LCMS 2005 (Fiedler and Lividini, 2014), we0
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Fig. 11. PVAM cumulative costs and cumulative DALYs saved, Zambia 2013–2021.
Source: Authors’ calculations.found that PVAM is not the only vitamin A intervention that is likely
to achieve high coverage in rural areas in Zambia. Despite Zambia’s
under-developed infrastructure andmarkets, two common vitamin
A fortiﬁcation vehicles also have high rural penetration rates: 63%
of the rural population purchases sugar (which has been fortiﬁed
in Zambia since 1996) and 63% purchases vegetable oil (which is
currently not fortiﬁed in Zambia). While the coverage and con-
sumption of these vehicles is greater in urban areas, it is clear that
rural markets for these vehicles are already substantially more
developed, leaving less space for PVAM’s incremental coverage
and impact, than had previously been thought existed. Still, the
addition of PVAM to the current vitamin A program portfolio of just
fortiﬁed sugarwould increase coverage an additional 25 percentage
points above sugar alone and provide 89% of rural Zambian house-
holds with the coverage of either PVAM or sugar or both (Fiedler
and Lividini, 2014). Given that neither sugar nor PVAM alone will
sufﬁciently alleviate the prevalence of inadequate vitamin A intake
in either rural or urban areas; that roughly 37% of the rural popula-
tion does not consume sugar; and that sugar already exhibits high
coverage and consumption rates in urban areas, biofortiﬁcation
provides an important complementary intervention to sugar.
A second implication of the PVAM’s transformation over time
from having a rural-concentrated impact to having an
urban-dominated impact is that it underscores the signiﬁcance of
the post-harvest PVAM market in conditioning PVAM’s long term
success. A better understanding of the characteristics of the market
through which biofortiﬁed crops are likely to be traded is essential
to crafting efforts to facilitate and accelerate its adoption, produc-
tion, consumption and impact. The rural-directed, supply-focused,
push strategy, must be complemented with an urban-directed,
demand-focused, pull strategy which over time is likely to become
as important in PVAM’s achieving scale and permanence.
Cultivating the urban-based PVAM market should not be regarded
as a strategy of secondary importance. After all, PVAM farmers’
sales of PVAM can also help to improve the nutrition status of their
households indirectly, by increasing incomes. PVAM can be and
should be promoted, therefore, as both a nutrition-speciﬁc, as well
as a nutrition-sensitive, intervention, and both push- and
pull-approaches should be developed as early-on in the program
as possible.
These two ﬁndings—the higher than expected rural coverage of
fortiﬁable foods and PVAM’s increasingly greater urban impact—
both underscore the need to adopt a new approach in analyzing
nutrition programs. They demonstrate the importance of supplant-
ing the piecemeal, program-by-program analysis with one that
analyzes biofortiﬁcation and fortiﬁcation as parts of a portfolio of
interventions in which individuals and households may be partic-
ipating simultaneously in order to understand changing needs, to
better economize on programs by adjusting scale and targeting
efforts, and to better protect public health from both inadequate
intakes as well as the risk of exposure to excess intakes.
Adopting such an approach will require the use of HCES or other
databases that are capable of examining the participation of indi-
viduals or households in multiple programs.
After an initial investment, costs fall dramatically resulting in a low
cost and cost-effective intervention
Time preference and risk averseness are important considera-
tions in assessing the costs of biofortiﬁcation, and in particular
its costs relative to other vitamin A interventions. As has been
shown, biofortiﬁcation’s costs are front-loaded, while its beneﬁts
accrue slowly. In contrast, both the costs and beneﬁts of other vita-
min A interventions are much more time invariant. In our compar-
ative analysis of vitamin A interventions in Zambia which uses the
same methodology (Fiedler and Lividini, 2014), we show that
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tions starting in 2019, making biofortiﬁcation the cheapest option
on an annual basis from that point forward. PVAM’s total cumula-
tive costs, however, remain much greater than those of other inter-
ventions’ for many years (14 for wheat ﬂour, 17 for CHW, and 20
for sugar). Over a 30 year period, biofortiﬁcation’s cumulative costs
never become less than those of vegetable oil.
The decision to invest in biofortiﬁcation therefore is not a sim-
ple one from a cost standpoint: it depends on a host of factors
including the time horizon for achieving target reductions in
micronutrient deﬁciency (rate of discount) and risk averseness,
as its beneﬁts accrue only slowly. In addition, it depends on the
long-term commitment to biofortiﬁcation that will be required in
order for it to become sustainable enough to produce greater ben-
eﬁts at lower costs over time. These outcomes are not inevitable,
and will require sustained commitment to achieve them.
A cost-effective intervention
As already discussed, based on WHO and World Bank bench-
marks, this study has found biofortiﬁcation is highly
cost-effective. Again, drawing on our Zambia portfolio analysis
(Fiedler and Lividini, 2014) of the cost-effectiveness of ﬁve other
vitamin A interventions in Zambia—vitamin A supplementation
through Child Health Week, vitamin A fortiﬁcation of sugar, veg-
etable oil, wheat ﬂour and maize meal—we found that over a
30 year accounting period PVAMwas less cost-effective than either
sugar or oil fortiﬁcation and vitamin A supplementation and more
cost-effective than either wheat ﬂour or maize meal fortiﬁcation.
In addition, the combination of biofortiﬁed PVAM and fortiﬁed
oil was found to be the most cost-effective 2-intervention portfolio.
This highlights the importance of explicitly identifying the com-
parator when discussing cost-effectiveness and drawing on a num-
ber of indicators. Even though (using WHO and World Bank
metrics) we ﬁnd biofortiﬁed PVAM is a cost-effective intervention
in Zambia, other criteria are necessary to determine which inter-
vention or portfolio of interventions should be implemented.
Which vitamin A intervention is ‘‘the best’’, and whether or not a
portfolio of vitamin A interventions should be implemented, are
distinct questions that may be addressed using cost-effectiveness
analysis, but requires additional criteria, such as the magnitude
of the public health impact (i.e., total DALYs saved), affordability
(total cost), coverage and effective coverage (see Fiedler and
Lividini, 2014 for further analysis and discussion). Moreover, given
the very different temporal characteristics of biofortiﬁcation’s cost
and beneﬁt streams vis-à-vis those of alternative vitamin A pro-
grams, the outcome of a cost-effectiveness analysis will depend
in part on the planning horizon: biofortiﬁcation will be relatively
less cost-effective for shorter-term planning periods.
PVAM is a long term investment: it will take more than a decade
for biofortiﬁed PVAM to begin ‘‘paying off’’. Once it does, however,
in each subsequent year throughout the remainder of the 30-year
analytic period and beyond, its net cumulative beneﬁts grow. It is
noteworthy, however, that fulﬁllment of PVAM’s promise as a very
cost-effective intervention cannot be considered a foregone conclu-
sion. It will require vigilance to ensure that the adoption and con-
sumption rates estimated here are achieved and maintained even
after PVAM’s active project cycle ends in 2019. It would be prudent,
therefore—particularly given the substantial front-loaded invest-
ment in PVAM—to consider extending the active project phase
beyond 2019 so as to ensure that the adoption and consumption
rates of the scenario analyzed here are achieved. While that, of
course, will mean some increase in costs with uncertain effects on
impacts (and thus might risk some reduction in PVAM’s estimated
cost-effectiveness), in light of PVAM’s high beneﬁt-cost ratio, how-
ever, there is room to be more cautious. It would seem prudent,therefore, to extend the active project phase, thereby reducing the
risks of its adoption and consumption rates not growing as quickly,
or not reaching the levels, assumed here. Another strategic consid-
eration would be to actively pursue ‘‘mainstreaming’’; the process
of breeding the enhanced nutrient content into an increasing num-
ber of all new seed varieties of the crop.
Biofortiﬁed maize will provide 50% of the EAR
Results of the modeling exercise suggest that by 2028–2030
PVAM will deliver a 10.6 percentage point increase in the average
EAR of the general population (Table 2). That level is expected to
edge up to 11.7 percentage points by 2040–2042, less than a quarter
of the 50% mark. When the analysis is limited to only PVAM con-
sumers, however, its average is considerably higher; among all
PVAM consumers, it will deliver 20–25% of the EAR, 22% among
women 15–49 years and 24% among children 4–6 years. Among
adopting farmers PVAM will deliver roughly 35% of the EAR, which
is 70% of the original target.
A number of factors contribute to PVAM’s impact being lower
than had initially been anticipated. First, estimated maize con-
sumption levels were found to be lower: women were assumed
to consume about 400 g/day and children 4–6 years were assumed
to consume 200 g/day. In this study, we found these ﬁgures to be
252 and 143 g/day. Moreover, in this study biofortiﬁed maize is
not expected to account for 100% of maize consumption: among
PVAM consumers it was estimated to be 117 g/day among women
and 71 g/day among children 4–6 years—29% and 36%, respec-
tively, of their initial estimated levels.
Second, the retention of provitamin A after cooking and storage
was assumed to be 50%, but was later found to be 37.5% (Mugode
et al., 2014). Third, and working in the opposite direction and con-
tributing to larger PVAM impacts than had originally been esti-
mated, the bioconversion rate of provitamin A to vitamin A
which had been assumed to be 12:1, was later found to be 6.5:1
(Li et al., 2010). These changes in the key drivers of PVAM’s impact
reﬂect the nascent nature of biofortiﬁcation, our still-evolving
understanding about how biofortiﬁcation programs will be imple-
mented and evolve, as well as the still evolving elements of nutri-
tion science needed to fully understand biofortiﬁcation.
These results suggest a number of policy implications. First, in
order to achieve the initial targets of delivering 50% of the EAR to
beneﬁciaries of PVAM, continuing to breed for higher levels of
provitamin A (above 15 ppm) and/or more stability of provitamin
A in the biofortiﬁed maize is essential. Second, engaging in effec-
tive behavioral change communication (BCC) campaigns to ensure
that those who adopt and grow PVAM primarily use it for their
own consumption will be important in order to maximize the ben-
eﬁts of PVAM. Prioritizing PVAM production for consumption will
help to achieve delivery of up to 50% of the EAR among growers
but may also reduce the added degradation of provitamin A that
is likely to occur as marketed PVAM moves through the value
chain. Finally, as noted above, sustained commitment to the active
project phase will be critical to achieving high rates of adoption of
PVAM, both for reaching a high proportion of rural farmers and
also for achieving considerable displacement of white maize by
PVAM in the market. Reaching such levels will be important to
ensuring that biofortiﬁcation’s impact extends beyond rural farm-
ers to those accessing PVAM through markets.
In sum, while the initial estimates were based on assumption
and simpliﬁed analyses, there continue to be many areas of uncer-
tainty underscoring the need for continued monitoring and updat-
ing of the analysis of biofortiﬁcation programs to provide feedback
into the management and design of biofortiﬁcation programs as
implementation progresses, in Zambia and elsewhere. In Zambia,
it looks as though biofortiﬁed PVAM will be a cost-effective,
76 K. Lividini, J.L. Fiedler / Food Policy 54 (2015) 65–77long-term, complementary vitamin A intervention, that will ini-
tially be focused in rural areas, but that over time and with sus-
tained commitment will have a spreading affect that will come
to make an important contribution to the vitamin A status of
Zambians in rural and urban areas.
Contextualization: The power of HCES in ex ante modeling of
biofortiﬁcation
The speciﬁc characteristics of biofortiﬁcation and othermicronu-
trient interventions, and the speciﬁc ways in which they might be
combinedwith the tradeoffs between potential intervention portfo-
lios in terms of coverage, cost and impact, is a function of a host of
country-speciﬁc considerations and underscores the importance of
using the highly contextualized approach of this study. That
approach consists of empirically developingmanyof the parameters
used in this analysis and using these parameters to model
biofortiﬁcation.
The central distinguishing feature of this approach is its model-
ing the likelihood of PVAM planting (as proxied by cultivating
hybrid maize) and the use of the ﬁtted equation to identify in the
LCMS the speciﬁc households that are likely to adopt. In most ex
ante adoption studies, these parameters are not
empirically-derived. More typically, national-level parameters are
assumed (Demont and Stein, 2013). By identifying the speciﬁc
farming households that adopt biofortiﬁed PVAM, this method pro-
vides a better understanding of the likely characteristics of PVAM
producers and consumers, and roots the study within the house-
hold level with the constellation of characteristics of actual
Zambian households. As such, it provides insights into how to iden-
tify those households and how to promote their adoption, both of
which can be important tools for designing, planning and monitor-
ing biofortiﬁcation interventions and better ensuring its success.
The important contextual considerations we derive from the
LCMS agriculture module data include: individual farmer proclivity
to adopt modern varieties, individual farm-size, individual farm
yield, howmuch of the biofortiﬁed crop is consumed by each house-
hold producing it and how much of it is sold. It also incorporates
important contextual considerations drawing on aspects of house-
holds’ consumption module data, including: whether or not the
household purchases the biofortiﬁed food, in what quantities and
what individuals’ apparent vitamin A intake status is before and
after consuming it. The particular strength of this highly contextu-
alized approach is that it empirically derives all four of the most
important measures in an ex ante analysis of the nutrition impact
of a biofortiﬁed crop within the same household—viz., the produc-
tion and the consumption of the biofortiﬁed crop, and the baseline
and endline nutrient intakes—rather than assuming their levels or
having to rely on distribution-free averages which mask important
effects and relationships.
One part of the contextualization of the study is our
empirically-informed approach to how we deﬁned the market
structure of PVAM. The comparison of the agriculture/production
and consumption modules revealed that each province is, or could
be, a largely independently functioning market, with Eastern and
Central Provinces as the only exceptions. We chose to be guided
by these empirical ﬁndings about the maize market to determine
the disposition of PVAM once it is produced, rather than adopting
the more conventional approach of ex ante analyses, which is to
assess impact using a single, nation-wide approach. Instead, it
was assumed that maize markets more closely approximate
provincial markets. Adopting this approach we found signiﬁcant
provincial variations in the quantity of PVAM consumed by house-
holds, how PVAM consumers acquired it and how the impact of
biofortiﬁcation varies by subpopulation. Given the widespread
availability of multi-purpose household consumption andexpenditure surveys similar to the LCMS used here (Fiedler et al.,
2012a), there is great opportunity for conducting similar studies
in many other countries, and similar types of assessment of biofor-
tiﬁed crops are underway or have been completed in Bangladesh,
India and elsewhere.
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Appendix A. Key assumptions of PVAM production and
consumption
The Key PVAM Production and Consumption Assumptions
1. Each adopting farming household plants 0.5 lima (1/4 ha) in
its ﬁrst year
2. Average yield for PVAM is 1.5 tons/ha or 375 kg/lima
3. Cumulative post-harvest losses of PVAM are estimated to
be 17.9%
4. In year 2 and each subsequent year, the farming household
continues planting PVAM. An additional 0.5 lima is planted
in PVAM; the maximum area that a farm may plant in
PVAM is the amount of land the farm currently plants in
maize
5. The concentration of provitamin A in PVAM is 7.5 ppm or
7.5 lg/g in 2013 and increases to 15 lg/g beginning in 2018
6. Retention of provitamin A in PVAM is 37.5%
7. The bioconversion rate of provitamin A carotenoids in
PVAM to vitamin A is assumed to be 6.5
8. Maize is primarily consumed in the form of nshima, a thick
porridge that is made by ﬁrst grinding or milling the maize
9. Different maize forms have different extraction rates:
breakfast meal = 70%, roller meal = 90%, hammer
meal = 90%
10. Initially, all PVAM produced is used for home consumption
and not sold. PVAM producers who produce more PVAM
than the amount of maize they consume from home
production, sell the excess PVAM. All PVAM that is sold is
assumed to be sold, purchased and consumed within the
same provincial market. Once the provincial market
demand is surfeited, PVAM is sold to consumers in other
provinces
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